Did you know that women generally suffer from more acute and chronic symptoms and use health services more frequently than men?
Recent research highlights significant knowledge gaps in the field of women’s health. Therefore there is a need to draw attention to new developments that improves the quality of life for women. Inura had the pleasure to be featured together with MOMM Diagnostics and Aspivix in an article about women’s health.
Would you like to know more about preeclampsia, intrauterine device, or Overactive Bladder syndrome? Check out this interesting article here.
Inura Medical AG (“Inura”) is a Swiss start-up company with a clear vision to make a difference in women’s health. Inura’s product is an innovative, first-of-a-kind “urethral ovulum” that utilizes a novel route of drug administration to treat diseases of the bladder and lower urinary tract. Inura’s technology results from decades of work in urology by Professor Grant S. Mulholland, a renowned surgeon, academic, and past President of the American Urology Association. The first indication we are addressing with the ovulum is a chronic disease, named overactive bladder (OAB). More details on https://inuramedical.ch/.